Maxim analyst Matthew Galinko initiated coverage of KindlyMD (NAKA) with a Buy rating and $8 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NAKA:
- Kindly MD Enters $5 Billion Sales Agreement
- KindlyMD announces $5B at-the-market equity offering program
- KindlyMD files automatic mixed securities shelf
- KindlyMD appoints Tim Pickett as CMO
- Crypto Currents: BlackRock ETF now holds 3% of all bitcoin